Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response

Taylor Geisman, MD

&

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

Christina Kratschmer, MD, PhD

Please Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for Zoom Details.